HERON THERAPEUTICS, INC. /DE/ Accumulated Other Comprehensive Income
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Accumulated Other Comprehensive Income of -$6.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-10
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$6.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$6.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $4.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$6.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | -$6.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $4.00K 10-Q · filed 2026-08-10 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-04 |
| 2025-06-30 | -$1.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $1.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | $13.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $40.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$8.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$6.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $13.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | -$1.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$6.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $9.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$19.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | -$57.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$11.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$8.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$6.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | -$4.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $41.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $121.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $257.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $540.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $953.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $708.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $85.00K 10-K · filed 2021-02-24 |
| 2019-09-30 | $103.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $148.00K 10-Q · filed 2019-08-05 |
| 2019-03-31 | $36.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$87.00K 10-K · filed 2020-03-02 |
| 2018-09-30 | -$42.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$25.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$42.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$10.00K 10-K · filed 2019-02-22 |
| 2017-06-30 | -$6.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$30.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$17.00K 10-K · filed 2018-02-27 |
| 2016-09-30 | -$17.00K 10-Q · filed 2016-11-08 |
| 2016-06-30 | -$1.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $1.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | -$40.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |